Serina Therapeutics, Inc.
SER
$5.70
-$0.15-2.56%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 56.00K | 3.16M | 3.17M | 3.13M | 3.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.00K | 3.16M | 3.17M | 3.13M | 3.15M |
| Cost of Revenue | 7.48M | 6.02M | 4.21M | 3.10M | 2.39M |
| Gross Profit | -7.42M | -2.87M | -1.04M | 33.00K | 765.00K |
| SG&A Expenses | 8.15M | 6.79M | 4.77M | 2.92M | 2.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.63M | 12.82M | 8.98M | 6.02M | 4.68M |
| Operating Income | -15.57M | -9.66M | -5.81M | -2.89M | -1.53M |
| Income Before Tax | -11.21M | -7.40M | -7.04M | -11.40M | 5.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.21 | -7.40 | -7.04 | -11.40 | 5.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.00K | 54.00K | 27.00K | 0.00 | -- |
| Net Income | -11.14M | -7.35M | -7.01M | -11.40M | 5.27M |
| EBIT | -15.57M | -9.66M | -5.81M | -2.89M | -1.53M |
| EBITDA | -15.38M | -9.52M | -5.67M | -2.79M | -1.44M |
| EPS Basic | -5.20 | -4.18 | -3.53 | -3.77 | 2.37 |
| Normalized Basic EPS | -1.48 | -0.85 | -1.20 | -1.80 | -0.26 |
| EPS Diluted | -5.04 | -4.59 | -4.49 | -4.88 | 0.70 |
| Normalized Diluted EPS | -1.56 | -1.22 | -1.38 | -1.76 | -0.04 |
| Average Basic Shares Outstanding | 38.69M | 22.57M | 15.91M | 9.56M | 8.94M |
| Average Diluted Shares Outstanding | 42.23M | 30.46M | 27.29M | 24.57M | 30.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |